Big Gain For Genprex, Inc.

Genprex, Inc. (GNPX:NASDAQ) soared at $4.28, representing a gain of 56.2%. On Thu 13 Feb 20, GNPX:NASDAQ hit a New 2-Week High of $2.74. The stock appeared on our News Catalysts scanner on Tue 11 Feb 20 at 02:17 PM in the 'AGREEMENT' category. From Fri 24 Jan 20, the stock recorded 57.14% Up Days and 46.67% Green Days

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.